Bioregulator Peptides: Uses, Courses and Product Differences
Healthy aging · organ-support claims
Bioregulators appeal to people looking for targeted help with joints, sleep, memory or healthy aging, often in short courses. The most useful starting point is the exact product—not the organ pictured on its label.
A synthetic peptide, an organ extract and an oral capsule are different preparations. Similar names do not make their effects or doses interchangeable.
First, check what is actually in it
Epitalon: four amino acids in a specific order.
Epithalamin: a pineal extract, not another name for that sequence.
Start with the goal, then the exact product
| Reader goal | Names they may encounter | The question to resolve |
|---|---|---|
| Healthy aging or sleep | Epitalon, Epithalamin | Is the cited study about the same preparation? |
| Joint comfort | Cartalax | Were pain and movement measured in people? |
| Lung or immune support | Chonluten, Vilon, Thymalin | Does a cell result translate into fewer symptoms or infections? |
| Cognition | Cortagen | Was the research in human brain function, or a different tissue? |
These are marketed associations, not a treatment-selection chart.
Doses and courses are product-specific
There is no single bioregulator dose or cycle. An oral capsule amount, an injected synthetic sequence and an organ-extract preparation cannot be substituted by matching milligrams.
An older 266-person follow-up examined Thymalin and Epithalamin preparations in elderly people over 6–8 years; one group received annual courses for six years. That is a study-specific schedule for those extracts, not support for a yearly course of every synthetic peptide in a catalog. Use each compound guide to check the exact product and any attributed dose example.
What bioregulator peptides are
These products grew out of Vladimir Khavinson’s research program. An amino-acid sequence identifies a molecule. Words such as “thymus,” “cartilage” or “vascular” describe where a preparation came from or what researchers hope to influence; they do not show where an injected or swallowed product will selectively travel.
From a peptide name to a useful claim
-
Identify the preparation
Is the study about a single sequence, a mixture extracted from tissue, or a finished commercial product?
-
Identify the experiment
A cell culture can reveal a biological response without showing absorption or an effect in a person.
-
Identify the outcome
Gene activity, symptoms and survival are different outcomes. Keep the claim at the level actually measured.
Names and sequences: examples you can check
| Name | Preparation in the cited research | What was investigated |
|---|---|---|
| Vilon | Lys–Glu, a two-amino-acid peptide | Responses in a cultured human monocyte/macrophage cell line |
| Chonluten | Glu–Asp–Gly, a three-amino-acid peptide | Responses in the same cell model |
| Epitalon | Ala–Glu–Asp–Gly, a four-amino-acid peptide | Cell signaling in that experiment |
| Thymalin | A peptide mixture | Included as a separate preparation, not interchangeable with the single sequences |
The 2022 THP-1 study is useful because it specifies the materials. It measured cellular responses, including inflammatory signaling, in a laboratory cell line. It was not a trial showing fewer infections or improved lung function.
Other catalog names include Cartalax, Cortagen, Livagen, Ovagen, Prostamax, Testagen and Vesugen. Treat each as a separate evidence question, not nine interchangeable “organ repair” treatments.
What the evidence actually shows
A study of fluorescently labeled short peptides showed entry into HeLa-cell nuclei and examined interactions with DNA in laboratory conditions. That supports a possible cellular interaction, not selective rejuvenation of an organ in a person. Original study.
The Cortagen microarray paper is another helpful example: despite the name’s brain association, this experiment examined gene expression in mouse heart. Describing it as proof of human nerve repair would change both the tissue and the endpoint. Original abstract.
These findings merit explanation rather than dismissal, but cell entry alone cannot answer how much reaches a human organ, whether symptoms improve or whether repeated exposure is safe.
Pharmacokinetics: modeled, not measured
A short sequence does not give every member of the family the same absorption or half-life. The cited experiments do not establish a shared human half-life or absorption percentage. Where a plot uses assumed rates, it illustrates those rates; it cannot prove a daily course or a repeating annual cycle is appropriate.
How to weigh the claims
Ask for the exact molecule, route, population and outcome. An oral product needs evidence about oral delivery; a cell-culture concentration is not a dose conversion. A paper about an extract cannot establish that a separately manufactured synthetic peptide has the same effects.
Frequently asked questions
What do sequence codes such as KE and AEDG mean?
They identify the amino acids in order. KE is the two-amino-acid Vilon sequence; AEDG is the four-amino-acid Epitalon sequence. The code identifies a molecule, not an organ-targeting guarantee.
Is an organ extract the same as its synthetic peptide?
No. An extract contains a mixture; a synthetic sequence is a distinct preparation. A study of one does not establish the same effect for the other.
Do bioregulator peptides selectively repair the organ in their name?
The cell experiments described here do not establish selective organ repair in people. A clinical claim needs evidence for the exact preparation, route and outcome.
Primary sources and their scope
- THP-1 peptide study, 2022: material identities and laboratory inflammatory responses.
- Nuclear-entry study, 2011: fluorescence-labeled peptides in HeLa cells and DNA experiments.
- Cortagen microarray study, 2004: mouse heart gene expression.
Related compounds & model context
Article citations are linked in the text. Related catalog entries have separate model inputs and source notes, which may include unverified estimates. See our methodology for model assumptions and limitations.